Signaling in this pathway might not only be directed from APCs or tumor cells toward CD96-expressing T cells and NK cells but there might also be a tumor cell-derived modification of APC-dependent cytokine production toward immunosuppression via T and NK cells as interim players [28]. The gene discussed is CD96; the disease is neoplasm.